Binding to the GC-rich structural domain of CD44, HnRNPM promotes the skipping of exon 8, which ultimately promotes breast cancer metastasis by enhancing TGFβ signaling and thus activating the switch of alternative splicing that occurs during epithelial-mesenchymal transition (EMT) (25, 34). This evidence concerns the gene CD44 and breast carcinoma.